Stephen J. Hoffman is Director at ALLOS THERAPEUTICS INC (ALTH). They have made 6 open-market trades across 4 companies since 2008, most recently 2026-06-22.
CIK 0001190418
6 open-market purchases totalling $19.1M since 2011, never a sale. Across 6 scored buys the stock is up 8.9% at ninety days, and 8.4 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 17% |
| Avg Move | -27.5% | -1.6% | +8.9% |
| Alpha | -22.7% | -1.3% | +8.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARPO | BUY | 2018-11-09 | 2018-11-14 | $2.01 | $124K | -16.7% | -5.6% | +57.4% |
| GNCA | BUY | 2015-03-17 | 2015-03-17 | $8.25 | $5.8M | -33.5% | -0.6% | -0.6% |
| GNCA | BUY | 2014-02-10 | 2014-02-11 | $12.00 | $3.0M | -33.5% | -0.6% | -0.6% |
| DRNA | BUY | 2014-02-04 | 2014-02-05 | $15.00 | $3.0M | -38.1% | -2.1% | -2.1% |
| ACRX | BUY | 2012-05-29 | 2012-05-31 | $3.40 | $968K | -21.8% | -0.4% | -0.4% |
| ACRX | BUY | 2011-02-16 | 2011-02-18 | $5.00 | $6.2M | -21.8% | -0.4% | -0.4% |
| ALTH | SELL · 10b5-1 | 2010-01-07 | 2010-01-11 | $7.06 | $962K | N/A | N/A | N/A |
| ALTH | SELL · 10b5-1 | 2010-01-04 | 2010-01-06 | $6.67 | $776K | N/A | N/A | N/A |
| ALTH | SELL · 10b5-1 | 2008-09-02 | 2008-09-03 | $9.68 | $387K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-24 close. 2 holdings could not be priced and are excluded from the total.